APA (7th ed.) Citation

Sulkowski, P. L., Corso, C. D., Robinson, N. D., Scanlon, S. E., Purshouse, K. R., Bai, H., . . . Bindra, R. S. (2017). 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity. Science translational medicine, 9(375), . https://doi.org/10.1126/scitranslmed.aal2463

Chicago Style (17th ed.) Citation

Sulkowski, Parker L., et al. "2-Hydroxyglutarate Produced by Neomorphic IDH Mutations Suppresses Homologous Recombination and Induces PARP Inhibitor Sensitivity." Science Translational Medicine 9, no. 375 (2017). https://doi.org/10.1126/scitranslmed.aal2463.

MLA (9th ed.) Citation

Sulkowski, Parker L., et al. "2-Hydroxyglutarate Produced by Neomorphic IDH Mutations Suppresses Homologous Recombination and Induces PARP Inhibitor Sensitivity." Science Translational Medicine, vol. 9, no. 375, 2017, https://doi.org/10.1126/scitranslmed.aal2463.